GOSS News

GOSS DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Gossamer Bio (GOSS) Investors of Securities Class Action Deadline on June 1, 2026 Ready to Announce with Confidence?

GOSS DEADLINE REMINDER: Bronstein, Gewirtz & Grossman LLC Reminds Gossamer Bio, Inc. Investors to Join the Class Action Lawsuit Today

GOSS DEADLINE NOTICE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Gossamer Bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 1 Deadline in Securities Class Action – GOSS

Pomerantz LLP Notifies Shareholders of Class Action Filing Against Gossamer Bio, Inc. – GOSS

Pomerantz LLP Notifies Shareholders of Class Action Lawsuit Against Gossamer Bio, Inc. – GOSS

GOSS 2-DAY DEADLINE ALERT: Gossamer Bio Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Concealed Placebo Risk: HBSS

GOSS CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Gossamer Bio (GOSS) Investors of Securities Class Action Deadline on June 1, 2026 Ready to Announce with Confidence?

GOSS IMPORTANT DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Gossamer Bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 1 Deadline in Securities Class Action - GOSS

Pomerantz LLP Notifies Shareholders of Class Action Against Gossamer Bio, Inc. – GOSS

Gossamer Bio, Inc. (GOSS) Faces Securities Class Action Amid 80% Drop On Phase 3 PROSERA Trial Failure– HBSS